Eating With Eosinophilic Esophagitis (EoE)

October 8, 2019 updated by: Jeffrey A Alexander, Mayo Clinic

Eating Behavior in Patients With Eosinophilic Esophagitis.

Is there a difference in the eating process for patients with active Eosinophilic Esophagitis (EoE) and those with inactive disease?

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Eosinophilic esophagitis (EoE) patients develop adapted eating behaviors to prevent symptoms. These patients tend to cut their food small, chew extensively, take copious liquids with meals, and avoid foods that cause symptoms. No studies to date have directly evaluated these eating behaviors in patients with EoE with observation. Furthermore, none of the investigators' current metrics for patient symptom assessment visually evaluate the eating process nor are they compared before and after treatment. As a result, it is unclear if a patient's subjective perception of their eating difficulties and improvement matches with objective measures.

Study Type

Observational

Enrollment (Actual)

31

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Minnesota
      • Rochester, Minnesota, United States, 55905
        • Mayo Clinic in Rochester

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Individuals with EoE that are being seen at Mayo Clinic Esophageal Clinic will be approached. Controls will be individuals who do not have an EoE diagnosis.

Description

Inclusion Criteria:

  • 18 years of age and older
  • Patients suspected to have Eosinophilic Esophagitis
  • Patients being treated for EoE with PPI or a steriod
  • EoE patients that are in remission by having less than 22 on the EEsAI questionnaire
  • Controls, patients that do not have EoE or other swallowing issues

Exclusion Criteria:

  • Clinical evidence of infectious process potentially contributing to dysphagia (candidiasis, CMV,herpes)
  • Other cause of dysphagia identified at endoscopy (reflux esophagitis, stricture, web, ring, achalasia, esophageal neoplasm)
  • EoE patients that do not eat sandwiches or feel they could not eat a sandwich.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Other
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Acitve EoE
Observed eating session of Jimmy John's turkey or vegetarian sandwich with water among individuals who have EoE who have not been treated or have not achieved remission from treatment.
Eating a Jimmy Johns turkey or vegetarian sandwich
Remission EoE
Observed eating session of Jimmy John's turkey or vegetarian sandwich with water among individuals who have EoE who are have achieved remission from treatment.
Eating a Jimmy Johns turkey or vegetarian sandwich
Controls
Observed eating session of Jimmy John's turkey or vegetarian sandwich with water among individuals without EoE.
Eating a Jimmy Johns turkey or vegetarian sandwich

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Observed eating session
Time Frame: 15-90 minutes
number of bites of patient's with EoE and controls eating a Jimmy John's sandwich
15-90 minutes

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Food slowness during eating session
Time Frame: 15-90 minutes
number of bites that felt stuck among patients with EoE and controls when eating a Jimmy John's sandwich
15-90 minutes
Water during eating session
Time Frame: 15-90 minutes
amount of water drank of patients with EoE and controls eating a Jimmy John's sandiwch
15-90 minutes
Eosinophilic Esophagitis activity Index (EEsAI) questionnaire
Time Frame: 10-15 minutes
The EEsAI Pro uses the VDQ is visual dysphagia question AMS is avoidance, modification, slow eating question . These two along with questions on frequency of, duration of, pain associated with dysphagia make up the PRO (patient reported outcomes). The PRO is a number (0-100) calculated from the answer to the questions. A PRO < 20 defines asymptomatic EoE.
10-15 minutes
Eosinophilic Esophagitis Quality of Life questionnaire
Time Frame: 10-15 minutes
Higher score denote better quality of life. 0-4 as follows 4=not at all, 3=Slightly 2=moderately, 1=Quite a bit, 0= Extremely
10-15 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Jeffrey A Alexander, Mayo Clinic

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 24, 2018

Primary Completion (Actual)

July 23, 2019

Study Completion (Actual)

July 23, 2019

Study Registration Dates

First Submitted

June 11, 2018

First Submitted That Met QC Criteria

June 26, 2018

First Posted (Actual)

July 10, 2018

Study Record Updates

Last Update Posted (Actual)

October 9, 2019

Last Update Submitted That Met QC Criteria

October 8, 2019

Last Verified

October 1, 2019

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Eosinophilic Esophagitis (EoE)

Clinical Trials on Observed eating session

3
Subscribe